177 related articles for article (PubMed ID: 34302657)
1. Contractile Force Measurement of Engineered Cardiac Tissues Derived from Human iPS Cells.
Sasaki D; Matsuura K; Shimizu T
Methods Mol Biol; 2021; 2320():161-170. PubMed ID: 34302657
[TBL] [Abstract][Full Text] [Related]
2. Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue.
Sasaki D; Matsuura K; Seta H; Haraguchi Y; Okano T; Shimizu T
PLoS One; 2018; 13(5):e0198026. PubMed ID: 29791489
[TBL] [Abstract][Full Text] [Related]
3. A Method for Contraction Force Measurement of hiPSC-Derived Engineered Cardiac Tissues.
Fujiwara Y; Deguchi K; Miki K; Nishimoto T; Yoshida Y
Methods Mol Biol; 2021; 2320():171-180. PubMed ID: 34302658
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering.
Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
Stem Cells Transl Med; 2013 Sep; 2(9):715-25. PubMed ID: 23884641
[TBL] [Abstract][Full Text] [Related]
5. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
6. Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.
Bielawski KS; Leonard A; Bhandari S; Murry CE; Sniadecki NJ
Tissue Eng Part C Methods; 2016 Oct; 22(10):932-940. PubMed ID: 27600722
[TBL] [Abstract][Full Text] [Related]
7. Generation of Cylindrical Engineered Cardiac Tissues from Human iPS Cell-Derived Cardiovascular Cell Lineages.
Masumoto H
Methods Mol Biol; 2021; 2320():81-88. PubMed ID: 34302650
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of contractile force and field potential of dynamically beating human iPS cell-derived cardiac cell sheet-tissue with flexible electronics.
Ohya T; Ohtomo H; Kikuchi T; Sasaki D; Kawamura Y; Matsuura K; Shimizu T; Fukuda K; Someya T; Umezu S
Lab Chip; 2021 Oct; 21(20):3899-3909. PubMed ID: 34636821
[TBL] [Abstract][Full Text] [Related]
9. Protocol for Morphological and Functional Phenotype Analysis of hiPS-Derived Cardiomyocytes.
Li J; Lee JK
Methods Mol Biol; 2021; 2320():91-100. PubMed ID: 34302651
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of Cardiac Constructs Using Bio-3D Printer.
Arai K; Murata D; Takao S; Nakayama K
Methods Mol Biol; 2021; 2320():53-63. PubMed ID: 34302647
[TBL] [Abstract][Full Text] [Related]
11. Effect of stem cell niche elasticity/ECM protein on the self-beating cardiomyocyte differentiation of induced pluripotent stem (iPS) cells at different stages.
Hirata M; Yamaoka T
Acta Biomater; 2018 Jan; 65():44-52. PubMed ID: 29066419
[TBL] [Abstract][Full Text] [Related]
12. Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness.
Lee S; Serpooshan V; Tong X; Venkatraman S; Lee M; Lee J; Chirikian O; Wu JC; Wu SM; Yang F
Biomaterials; 2017 Jul; 131():111-120. PubMed ID: 28384492
[TBL] [Abstract][Full Text] [Related]
13. Engineered Heart Tissues for Contractile, Structural, and Transcriptional Assessment of Human Pluripotent Stem Cell-Derived Cardiomyocytes in a Three-Dimensional, Auxotonic Environment.
Bremner S; Goldstein AJ; Higashi T; Sniadecki NJ
Methods Mol Biol; 2022; 2485():87-97. PubMed ID: 35618900
[TBL] [Abstract][Full Text] [Related]
14. Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
Iseoka H; Miyagawa S; Fukushima S; Saito A; Masuda S; Yajima S; Ito E; Sougawa N; Takeda M; Harada A; Lee JK; Sawa Y
Tissue Eng Part A; 2018 Feb; 24(3-4):287-300. PubMed ID: 28498040
[TBL] [Abstract][Full Text] [Related]
15. Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells.
Gao L; Zhang JJ
Methods Mol Biol; 2021; 2158():187-197. PubMed ID: 32857374
[TBL] [Abstract][Full Text] [Related]
16. TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues.
Matsuura K; Seta H; Haraguchi Y; Alsayegh K; Sekine H; Shimizu T; Hagiwara N; Yamazaki K; Okano T
Sci Rep; 2016 Feb; 6():21747. PubMed ID: 26888607
[TBL] [Abstract][Full Text] [Related]
17. Measuring the Contractile Force of Multilayered Human Cardiac Cell Sheets.
Sakaguchi K; Takahashi H; Tobe Y; Sasaki D; Matsuura K; Iwasaki K; Shimizu T; Umezu M
Tissue Eng Part C Methods; 2020 Sep; 26(9):485-492. PubMed ID: 32799760
[TBL] [Abstract][Full Text] [Related]
18. Human induced pluripotent stem cell-derived fiber-shaped cardiac tissue on a chip.
Morimoto Y; Mori S; Sakai F; Takeuchi S
Lab Chip; 2016 Jun; 16(12):2295-301. PubMed ID: 27217209
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.
Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
Methods Mol Biol; 2016; 1357():415-21. PubMed ID: 25520285
[TBL] [Abstract][Full Text] [Related]
20. Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes.
Park J; Anderson CW; Sewanan LR; Kural MH; Huang Y; Luo J; Gui L; Riaz M; Lopez CA; Ng R; Das SK; Wang J; Niklason L; Campbell SG; Qyang Y
Acta Biomater; 2020 Jan; 102():220-230. PubMed ID: 31634626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
